外科用イメージ市場規模、シェア、動向、2030年までの世界予測

外科用イメージ市場 – 製品 [手術ナビゲーションソフトウェア、システム（Cアーム、CT、超音波、統合型MR-OR）]、ブランド（Azurion、StealthStation、Ingenia、Nexaris）、用途（MIS、内視鏡、CVD、OB/GYN、整形外科、神経）、エンドユーザー – 2030年までの世界予測

外科用イメージ市場は2025年に540万米ドルと評価され、2030年には1,220万米ドルに達すると予測されており、予測期間中に年平均成長率（CAGR）17.6%を記録します。これは、高度な術中イメージング技術の利用増加、AI駆動型画像解析と拡張現実（AR）による手術ナビゲーションの統合、そして病院や外来手術センターにおけるハイブリッド手術室の設置拡大によるものです。手術精度の向上、処置時間の短縮、患者転帰の改善に対するニーズに加え、保険償還政策の充実、そしてイメージングソフトウェアと接続ソリューションの継続的な革新によって、需要はさらに高まっています。

• 製品、ブランド、用途、エンドユーザー、地域に基づいて外科用画像診断市場を調査しています。
• 市場の成長に影響を与える要因（推進要因、制約要因、機会、課題など）を分析しています。
• 利害関係者にとっての市場における機会と課題を評価し、市場リーダーの競争環境の詳細を提供しています。
• マイクロ市場の成長傾向、見通し、そして外科用画像診断市場全体への貢献について調査しています。
• 5つの主要地域における市場セグメントの収益予測を行っています。

本レポートは、既存企業だけでなく新規参入企業や小規模企業にとっても、市場の動向を把握し、シェア拡大に繋げる上で役立ちます。本レポートをご購入いただいた企業は、以下の5つの戦略のいずれか、または組み合わせて活用いただけます。

The surgical imaging market was valued at USD 5.4 million in 2025 and is estimated to reach USD 12.2 million by 2030, registering a CAGR of 17.6% during the forecast period. This is due to the increased use of advanced intraoperative imaging technologies, integration of AI-driven image analysis and augmented reality for surgical navigation, and the expanding installation of hybrid operating rooms in hospitals and outpatient surgical centers. The demand is further boosted by the need for greater surgical precision, shorter procedure times, and better patient outcomes, along with supportive reimbursement policies and ongoing innovations in imaging software and connectivity solutions.

“The orthopedic & musculoskeletal surgery segment is estimated to hold the largest share of the surgical imaging market in 2024.”

By application, the orthopedic & musculoskeletal surgery segment is expected to hold the largest share of the surgical imaging market in 2024 due to the high demand for precise, real-time imaging across various orthopedic and musculoskeletal procedures, including knee and hip replacements, scoliosis correction, and complex surgeries. Advanced technologies such as C-arm systems, 3D imaging, and intraoperative CT allow surgeons to accurately position implants, verify bone alignment, and evaluate surgical outcomes immediately, thereby reducing the risk of complications or needing revisions. The increasing number of orthopedic surgeries, driven by sports injuries, traffic accidents, and age-related degenerative conditions, has further boosted the adoption of surgical imaging solutions in this field segment.

“North America accounts for the largest market share in the surgical imaging market in 2024.”

The North American market led the surgical imaging market in 2024. This leadership is driven by factors such as the region’s advanced healthcare infrastructure, high adoption of next-generation intraoperative imaging technologies, and strong integration of AI-powered visualization and data management systems. The growing number of complex surgical procedures in US and Canadian hospitals, along with the rapid growth of hybrid operating rooms equipped with real-time imaging, has further solidified this position. Favorable reimbursement policies, a high concentration of top medical technology companies, and ongoing investments in surgical innovation also support North America’s market leadership.

In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the surgical imaging marketplace.

The breakdown of primary participants is as mentioned below:

• By Company Type – Tier 1 (48%), Tier 2 (36%), and Tier 3 (16%)
• By Designation – Directors (15%), Managers (10%), and Others (75%)
• By Region – North America (39%), Europe (31%), the Asia Pacific (21%), and Latin America (6%), and the Middle East & Africa (3%)

Key Players in the Surgical Imaging Market

Prominent players in the surgical imaging market include GE HealthCare (US), Siemens Healthineers AG(Germany), Koninklijke Philips N.V. (Netherlands), Shimadzu Corporation (Japan), Fujifilm Holdings Corporation (Japan), Ziehm Imaging GmbH (Germany), Hologic, Inc. (US), Smith & Nephew (UK), Medtronic (Ireland), United Imaging Healthcare Co. Ltd. (China), Canon Inc. (Japan), Stryker (US), Olympus Corporation (Japan), Novanta Inc. (US), Global Medical (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Sony Electronics Inc. (Japan), Barco (Belgium), Brainlab SE (UK), Auxein (US), Trivitron Healthcare (India), RGS Healthcare (US), GEMSS HEALTHCARE Co., Ltd. (South Korea), Skanray Technologies Limited (India), Nanjing Perlove Medical Equipment Co., Ltd. (China), Arthrex, Inc. (Florida).

Players adopted both organic and inorganic growth strategies, such as product launches and improvements, investments, partnerships, collaborations, joint ventures, funding, acquisitions, expansions, agreements, contracts, and alliances, to increase their offerings, address unmet customer needs, boost profitability, and expand their presence in the global market.

The study features a detailed competitive analysis of major players in the surgical imaging market, including their company profiles, recent updates, and primary market strategies.

Research Coverage

• The report studies the surgical imaging market based on product, brand, application, end user, and region.
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
• The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total surgical imaging market.
• The report forecasts the revenue of market segments with respect to five major regions.

Reasons to Buy the Report

The report can help established firms as well as new entrants/smaller firms gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the five strategies mentioned below.

This report provides insights into the following pointers:

Analysis of key drivers (technological advancements in surgical imaging modalities, rising demand for minimally invasive surgeries, technological transition to flat-panel detectors and hybrid ORs, expanding applications across surgical specialties), restraints (high equipment costs of surgical imaging systems, interoperability challenges with existing hospital systems, hospital cost cut), opportunities (increasing number of surgical procedures conducted in ambulatory surgical centers, development of hybrid operating rooms, growing demand for data-integrated imaging systems), and challenges (shortage of skilled workforce, imaging obese patients, hospital budget cuts) influencing the industry macrodynamics of surgical imaging market.

• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the surgical imaging market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of surgical imaging across regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the surgical imaging market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the surgical imaging market.

Table of Contents

1               INTRODUCTION              25

1.1           STUDY OBJECTIVES       25

1.2           MARKET DEFINITION   25

1.2.1        INCLUSIONS & EXCLUSIONS       26

1.3           MARKET SCOPE                27

1.3.1        MARKETS AND REGIONS COVERED         27

1.3.2        YEARS CONSIDERED      28

1.4           CURRENCY CONSIDERED            28

1.5           LIMITATIONS    28

1.5.1        METHODOLOGY-RELATED LIMITATIONS           29

1.5.2        SCOPE-RELATED LIMITATIONS                 29

1.6           MARKET STAKEHOLDERS            29

1.7           SUMMARY OF CHANGES               29

2               RESEARCH METHODOLOGY       31

2.1           RESEARCH DATA              31

2.1.1        SECONDARY DATA          32

2.1.1.1    List of secondary sources    32

2.1.2        PRIMARY DATA SOURCES            33

2.1.2.1    List of key primary stakeholders interviewed   33

2.1.2.2    Insights from primary experts             34

2.2           MARKET ESTIMATION METHODOLOGY               35

2.2.1        APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH         37

2.2.2        APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION     37

2.2.3        PRIMARY RESEARCH VALIDATION           38

2.3           GROWTH RATE ASSUMPTIONS 39

2.4           DATA TRIANGULATION AND MARKET BREAKDOWN                 40

2.5           RESEARCH ASSUMPTIONS           41

2.5.1        STUDY ASSUMPTIONS  41

2.6           RESEARCH LIMITATIONS             41

2.7           RISK ASSESSMENT           42

3               EXECUTIVE SUMMARY  43

4               PREMIUM INSIGHTS       49

4.1           ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN SURGICAL IMAGING MARKET    49

4.2           ASIA PACIFIC: SURGICAL IMAGING MARKET, BY PRODUCT           50

4.3           SURGICAL IMAGING MARKET, BY KEY COUNTRY/REGION         51

4.4           REGIONAL MIX: SURGICAL IMAGING MARKET   52

4.5           SURGICAL IMAGING MARKET: DEVELOPED VS. EMERGING ECONOMIES               53

5               MARKET OVERVIEW       54

5.1           INTRODUCTION              54

5.2           MARKET DYNAMICS       54

5.2.1        DRIVERS               55

5.2.1.1    Technological advancements in surgical imaging modalities                 55

5.2.1.2    Rising demand for minimally invasive surgeries              56

5.2.1.3    Technological transition to flat-panel detectors and hybrid operating rooms   56

5.2.1.4    Expanding applications across surgical specialties          57

5.2.2        RESTRAINTS      57

5.2.2.1    High equipment costs of surgical imaging systems         57

5.2.2.2    Interoperability challenges with existing hospital systems                 57

5.2.3        OPPORTUNITIES              58

5.2.3.1    Increasing number of surgical procedures conducted in ASCs (ambulatory surgical centers)             58

5.2.3.2    Development of hybrid operating rooms (ORs)              58

5.2.3.3    Growing demand for data-integrated imaging systems 58

5.2.4        CHALLENGES    59

5.2.4.1    Shortage of skilled workforce              59

5.2.4.2    Imaging obese patients        59

5.2.4.3    Hospital budget cuts            60

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS            60

5.4           INDUSTRY TRENDS         61

5.4.1        INTEGRATION OF ARTIFICIAL INTELLIGENCE AND ADVANCED ANALYTICS                61

5.4.2        AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN SURGERY             62

5.4.3        GROWTH OF HYBRID OPERATING ROOMS AND MULTIMODAL IMAGING              62

5.4.4        COMPACT, MOBILE, AND LOW-DOSE IMAGING TECHNOLOGIES               62

5.4.5        INTEGRATION WITH SURGICAL ROBOTICS AND ADVANCED 3D/4D IMAGING      62

5.5           PRICING ANALYSIS          63

5.5.1        AVERAGE SELLING PRICE OF SURGICAL IMAGING PRODUCTS, BY TYPE     63

5.5.2        AVERAGE SELLING PRICE OF SURGICAL IMAGING PRODUCTS, BY KEY PLAYER       64

5.5.3        PRICING MODELS            66

5.6           VALUE CHAIN ANALYSIS               67

5.6.1        RESEARCH & DEVELOPMENT    68

5.6.2        MANUFACTURING & ASSEMBLY                68

5.6.3        DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES             68

5.7           SUPPLY CHAIN ANALYSIS             69

5.7.1        PROMINENT COMPANIES            69

5.7.2        SMALL & MEDIUM-SIZED ENTERPRISES 69

5.7.3        END USERS         69

5.8           ECOSYSTEM ANALYSIS  69

5.9           INVESTMENT AND FUNDING SCENARIO               72

5.10         TECHNOLOGY ANALYSIS             72

5.10.1      KEY TECHNOLOGIES     72

5.10.1.1  Intraoperative imaging systems          72

5.10.1.2  Image-guided surgery and navigation systems                 73

5.10.2      COMPLEMENTARY TECHNOLOGIES       73

5.10.2.1  Radiopharmaceutical development and theranostics      73

5.10.2.2  Advanced computing and big data analytics    73

5.10.3      ADJACENT TECHNOLOGIES       73

5.10.3.1  Endoscopic & laparoscopic imaging systems   73

5.10.3.2  AI/Image analytics solutions               74

5.11         PATENT ANALYSIS          74

5.12         TRADE ANALYSIS             77

5.12.1      IMPORT DATA FOR SURGICAL IMAGING PRODUCTS (HS CODE 9022)         78

5.12.2      EXPORT DATA FOR SURGICAL IMAGING PRODUCTS (HS CODE 9022)         79

5.13         KEY CONFERENCES AND EVENTS, 2025–2026        79

5.14         CASE STUDY ANALYSIS 80

5.14.1      ADVANCING ENDOSCOPIC SINUS AND SKULL BASE SURGERY WITH SURGICAL NAVIGATION AT GMCH-32   80

5.14.2      PRECISION MAXILLOFACIAL SURGERY THROUGH BRAINLAB’S INTRAOPERATIVE NAVIGATION AND CT INTEGRATION  81

5.14.3      AI-POWERED REAL-TIME TUMOR MARGIN DETECTION IN SKULL BASE SURGERY WITH STIMULATED RAMAN HISTOLOGY       81

5.15         TARIFF AND REGULATORY LANDSCAPE               82

5.15.1      TARIFF DATA FOR HS CODE 9022              82

5.15.2      REGULATORY LANDSCAPE         83

5.15.3      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             83

5.15.4      REGULATORY TRENDS 85

5.15.4.1  North America      85

5.15.4.1.1                US           85

5.15.4.1.2                Canada   87

5.15.5      EUROPE               88

5.15.6      ASIA PACIFIC     88

5.15.6.1  Japan      88

5.15.6.2  China      89

5.15.6.3  India       91

5.15.6.4  Middle East (GCC Region)                 91

5.15.6.4.1                UAE        91

5.15.6.4.2                Saudi Arabia          91

5.15.6.5  Africa      91

5.16         REIMBURSEMENT SCENARIO ANALYSIS                 92

5.17         PORTER’S FIVE FORCES ANALYSIS           93

5.17.1      BARGAINING POWER OF SUPPLIERS       95

5.17.2      BARGAINING POWER OF BUYERS             95

5.17.3      THREAT OF NEW ENTRANTS      95

5.17.4      THREAT OF SUBSTITUTES          95

5.17.5      INTENSITY OF COMPETITIVE RIVALRY 95

5.18         KEY STAKEHOLDERS AND BUYING CRITERIA     95

5.18.1      KEY STAKEHOLDERS IN BUYING PROCESS           96

5.18.2      BUYING CRITERIA           97

5.19         UNMET NEEDS ANALYSIS             97

5.19.1      CURRENT UNMET NEEDS            97

5.19.2      END-USER EXPECTATIONS         99

5.20         BUSINESS MODEL            100

5.20.1      CAPITAL EQUIPMENT SALES MODEL     100

5.20.2      SUBSCRIPTION AND SAAS MODEL           100

5.20.3      PAY-PER-USE/TRANSACTION-BASED MODEL    100

5.20.4      MANAGED SERVICES MODEL     100

5.20.5      VALUE-BASED/OUTCOME-DRIVEN MODEL        100

5.20.6      HYBRID MODEL (BUNDLED HARDWARE + DIGITAL SERVICES)           100

5.21         IMPACT OF AI/GEN AI ON SURGICAL IMAGING MARKET                 101

5.21.1      INTRODUCTION              101

5.21.2      MARKET POTENTIAL OF AI/GEN AI IN SURGICAL IMAGING MARKET           102

5.21.3      CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION         103

5.21.3.1  AI-assisted intraoperative imaging for enhanced detection of peritoneal metastases           103

5.21.4      IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS              104

5.21.4.1  Surgical navigation & visualization software    104

5.21.4.2  Operating room integration platforms              105

5.21.4.3  Intraoperative imaging systems (CT, MRI, fluoroscopy, ultrasound)            105

5.21.5      USER READINESS AND IMPACT ASSESSMENT     105

5.21.5.1  User readiness       105

5.21.5.1.1                User A: Hospitals 105

5.21.5.1.2                User B: Ambulatory surgical clinics (ASCs)    105

5.21.5.2  Impact assessment                106

5.21.5.2.1                User A: Hospitals 106

5.21.5.2.1.1            Implementation    106

5.21.5.2.1.2            Impact    106

5.21.5.2.2                User B: Ambulatory surgical clinics (ASCs)    106

5.21.5.2.2.1            Implementation    106

5.21.5.2.2.2            Impact    106

5.22         IMPACT OF 2025 US TARIFF – OVERVIEW               107

5.22.1      INTRODUCTION              107

5.22.2      KEY TARIFF RATES          107

5.22.3      PRICE IMPACT ANALYSIS             108

5.22.4      IMPACT ON COUNTRY/REGION                109

5.22.4.1  US           109

5.22.4.2  EUROPE               109

5.22.4.3  ASIA PACIFIC     109

5.22.5      IMPACT ON END-USE INDUSTRIES          109

5.22.6      CONCLUSION    110

6               SURGICAL IMAGING MARKET, BY PRODUCT      111

6.1           INTRODUCTION              112

6.2           C-ARMS                 112

6.2.1        C-ARMS ENHANCING SURGICAL OUTCOMES THROUGH REAL-TIME FLUOROSCOPIC IMAGING TO DRIVE MARKET                 112

6.3           CT SCANNERS   115

6.3.1        ENHANCED OPERATIVE CARE WITH HIGH-ACCURACY INTRAOPERATIVE IMAGING TO DRIVE ADOPTION OF CT SCANNERS          115

6.4           ULTRASOUND SYSTEMS               118

6.4.1        ULTRASOUND ADVANCING SURGICAL PRECISION THROUGH REAL-TIME INTRAOPERATIVE IMAGING TO DRIVE SEGMENTAL GROWTH  118

6.5           INTEGRATED MR-OR SYSTEMS 120

6.5.1        INTEGRATED MR OR SYSTEMS DRIVING SURGICAL ACCURACY THROUGH REAL-TIME SOFT TISSUE IMAGING                 120

6.6           SURGICAL NAVIGATION SOFTWARE      123

6.6.1        GROWING USE OF SURGICAL NAVIGATION SOFTWARE DRIVING OPERATIVE PRECISION WITH REAL-TIME GUIDANCE                 123

6.7           ACCESSORIES    125

6.7.1        INCREASING ADOPTION OF SURGICAL IMAGING ACCESSORIES TO DRIVE ENHANCED VISUALIZATION AND WORKFLOW EFFICIENCY             125

7               SURGICAL IMAGING MARKET, BY APPLICATION                 128

7.1           INTRODUCTION              129

7.2           PROCEDURE TYPE          129

7.2.1        MINIMALLY INVASIVE SURGERY               130

7.2.1.1    Rising adoption of minimally invasive techniques driving precision and faster recovery in surgical imaging            130

7.2.2        LAPAROSCOPY 131

7.2.2.1    Enhanced precision and faster recovery driving increased adoption of laparoscopic imaging      131

7.2.3        ENDOSCOPY      132

7.2.3.1    Real-time internal visualization driving growth in endoscopic imaging  132

7.2.4        OTHER PROCEDURES    133

7.3           SURGERY TYPE 134

7.3.1        GENERAL SURGERY        136

7.3.1.1    Enhanced visualization transforming general surgical procedures to fuel growth        136

7.3.2        CARDIOVASCULAR SURGERY     136

7.3.2.1    Advanced imaging techniques enhancing cardiovascular interventions to fuel growth                136

7.3.3        OB/GYN SURGERY           137

7.3.3.1    Growing use of imaging-guided precision driving improved surgical outcomes in OB/GYN procedures      137

7.3.4        ORTHOPEDIC & MUSCULOSKELETAL SURGERY                 138

7.3.4.1    Adoption of imaging solutions driving optimized implant placement and bone alignment           138

7.3.5        NEUROSURGERY              139

7.3.5.1    High-precision imaging navigating complex neural procedures to drive market          139

7.3.6        UROLOGY SURGERY       140

7.3.6.1    Imaging-guided precision improving outcomes in urological surgeries to drive demand   140

7.3.7        OTHER SURGERIES         141

8               SURGICAL IMAGING MARKET, BY END USER       143

8.1           INTRODUCTION              144

8.2           HOSPITALS & SURGICAL CENTERS          144

8.2.1        RISING SURGICAL VOLUMES IN HOSPITALS AND SURGICAL CENTERS TO DRIVE MARKET               144

8.3           SPECIALTY CLINICS        145

8.3.1        SPECIALTY CLINICS DRIVING SURGICAL IMAGING ADOPTION THROUGH PRECISION AND EFFICIENCY      145

8.4           AMBULATORY SURGICAL CENTERS        146

8.4.1        AMBULATORY SURGICAL CENTERS DRIVING SURGICAL IMAGING ADOPTION FOR EFFICIENT OUTPATIENT CARE                 146

8.5           OTHER END USERS         147

9               SURGICAL IMAGING MARKET, BY REGION           149

9.1           INTRODUCTION              150

9.2           NORTH AMERICA             151

9.2.1        MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 151

9.2.2        US           155

9.2.2.1    Advancements in AI and augmented reality integration in surgery to drive market      155

9.2.3        CANADA               156

9.2.3.1    Collaborations between national AI institutes and health systems to drive market      156

9.3           EUROPE               157

9.3.1        MACROECONOMIC OUTLOOK FOR EUROPE      158

9.3.2        GERMANY           161

9.3.2.1    Precision-driven imaging and expanding hospital capacity to drive regional growth           161

9.3.3        UK          162

9.3.3.1    NHS-led integration of surgical imaging and skilled workforce strength to drive regional growth       162

9.3.4        FRANCE                163

9.3.4.1    Steady growth in radiology workforce supporting imaging expansion               163

9.3.5        ITALY    164

9.3.5.1    Balancing imaging modernization with workforce shortages                 164

9.3.6        SPAIN    165

9.3.6.1    Expanding surgical imaging access with focus on regional equity                 165

9.3.7        REST OF EUROPE             166

9.4           ASIA PACIFIC     167

9.4.1        MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 167

9.4.2        JAPAN   172

9.4.2.1    Enhancing surgical outcomes with innovative imaging technologies           172

9.4.3        CHINA  173

9.4.3.1    Strong network of grade-A tertiary hospitals driving advanced imaging adoption 173

9.4.4        INDIA    174

9.4.4.1    Government initiatives and private hospital collaborations to fuel growth    174

9.4.5        SOUTH KOREA  175

9.4.5.1    Rising aging population driving demand for precision surgical imaging  175

9.4.6        AUSTRALIA         176

9.4.6.1    Strengthening surgical imaging capabilities for minimally invasive procedures              176

9.4.7        REST OF ASIA PACIFIC   177

9.5           LATIN AMERICA                178

9.5.1        MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 178

9.5.2        BRAZIL 182

9.5.2.1    Government and private investment in surgical infrastructure to drive market          182

9.5.3        MEXICO                183

9.5.3.1    Accelerating minimally invasive and AI-enabled surgical imaging to drive market      183

9.5.4        REST OF LATIN AMERICA             184

9.6           MIDDLE EAST & AFRICA                185

9.6.1        MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 185

9.6.2        GCC COUNTRIES              189

9.6.2.1    Rising healthcare demand and innovation driving surgical imaging advancements        189

9.6.3        REST OF MIDDLE EAST & AFRICA             190

10            COMPETITIVE LANDSCAPE         191

10.1         OVERVIEW          191

10.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            191

10.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SURGICAL IMAGING MARKET               192

10.3         REVENUE ANALYSIS, 2020–2024  193

10.4         MARKET SHARE ANALYSIS, 2024                 194

10.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 197

10.5.1      STARS   197

10.5.2      EMERGING LEADERS     197

10.5.3      PERVASIVE PLAYERS      197

10.5.4      PARTICIPANTS 198

10.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         199

10.5.5.1  Company footprint               199

10.5.5.2  Region footprint   200

10.5.5.3  Product footprint  201

10.5.5.4  Application (procedure type) footprint             202

10.5.5.5  Application (surgery type) footprint 203

10.5.5.6  End-user footprint                204

10.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        205

10.6.1      PROGRESSIVE COMPANIES         205

10.6.2      RESPONSIVE COMPANIES            205

10.6.3      DYNAMIC COMPANIES  205

10.6.4      STARTING BLOCKS         205

10.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 207

10.6.5.1  Detailed list of key startups/SMEs    207

10.6.5.2  Competitive benchmarking of emerging players/startups                 208

10.7         COMPANY VALUATION & FINANCIAL METRICS 208

10.7.1      FINANCIAL METRICS      208

10.7.2      COMPANY VALUATION 209

10.8         BRAND/PRODUCT COMPARISON             210

10.9         COMPETITIVE SCENARIO             211

10.9.1      PRODUCT LAUNCHES   211

10.9.2      DEALS  212

10.9.3      EXPANSIONS     213

11            COMPANY PROFILES      214

11.1         KEY PLAYERS     214

11.1.1      GE HEALTHCARE             214

11.1.1.1  Business overview 214

11.1.1.2  Products offered   216

11.1.1.3  Recent developments           217

11.1.1.3.1                Product launches & approvals            217

11.1.1.3.2                Deals      219

11.1.1.3.3                Expansions             223

11.1.1.4  MnM view              223

11.1.1.4.1                Right to win           223

11.1.1.4.2                Strategic choices   223

11.1.1.4.3                Weaknesses & competitive threats     224

11.1.2      SIEMENS HEALTHINEERS AG      225

11.1.2.1  Business overview 225

11.1.2.2  Products offered   227

11.1.2.3  Recent developments           229

11.1.2.3.1                Product launches & approvals            229

11.1.2.3.2                Deals      231

11.1.2.3.3                Other developments             232

11.1.2.3.4                Expansions             232

11.1.2.4  MnM view              233

11.1.2.4.1                Right to win           233

11.1.2.4.2                Strategic choices   233

11.1.2.4.3                Weaknesses & competitive threats     233

11.1.3      KONINKLIJKE PHILIPS N.V.          234

11.1.3.1  Business overview 234

11.1.3.2  Products offered   236

11.1.3.3  Recent developments           237

11.1.3.3.1                Product launches & approvals            237

11.1.3.3.2                Deals      239

11.1.3.4  MnM view              240

11.1.3.4.1                Right to win           240

11.1.3.4.2                Strategic choices   240

11.1.3.4.3                Weaknesses & competitive threats     240

11.1.4      SHIMADZU CORPORATION         241

11.1.4.1  Business overview 241

11.1.4.2  Products offered   243

11.1.4.3  Recent developments           244

11.1.4.3.1                Product launches & approvals            244

11.1.4.3.2                Deals      245

11.1.4.4  MnM view              245

11.1.4.4.1                Right to win           245

11.1.4.4.2                Strategic choices   245

11.1.4.4.3                Weaknesses & competitive threats     246

11.1.5      FUJIFILM HOLDINGS CORPORATION     247

11.1.5.1  Business overview 247

11.1.5.2  Products offered   249

11.1.5.3  Recent developments           250

11.1.5.3.1                Product launches & approvals            250

11.1.5.3.2                Deals      250

11.1.5.4  MnM view              251

11.1.5.4.1                Right to win           251

11.1.5.4.2                Strategic choices   251

11.1.5.4.3                Weaknesses & competitive threats     252

11.1.6      ZIEHM IMAGING GMBH                 253

11.1.6.1  Business overview 253

11.1.6.2  Products offered   253

11.1.6.3  Recent developments           255

11.1.6.3.1                Product launches & approvals            255

11.1.6.3.2                Deals      255

11.1.7      HOLOGIC, INC. 256

11.1.7.1  Business overview 256

11.1.7.2  Products offered   258

11.1.7.3  Recent developments           259

11.1.7.3.1                Deals      259

11.1.8      SMITH+NEPHEW              260

11.1.8.1  Business overview 260

11.1.8.2  Products offered   261

11.1.8.3  Recent developments           262

11.1.8.3.1                Product launches & approvals            262

11.1.8.3.2                Deals      262

11.1.9      MEDTRONIC      263

11.1.9.1  Business overview 263

11.1.9.2  Products offered   264

11.1.9.3  Recent developments           266

11.1.9.3.1                Product launches & approvals            266

11.1.9.3.2                Deals      266

11.1.10   STRYKER              267

11.1.10.1                 Business overview 267

11.1.10.2                 Products offered   268

11.1.10.3                 Recent developments           269

11.1.10.3.1             Product launches & approvals            269

11.1.10.3.2             Deals      269

11.1.11   CANON MEDICAL SYSTEMS CORPORATION        270

11.1.11.1                 Business overview 270

11.1.11.2                 Products offered   272

11.1.11.3                 Recent developments           273

11.1.11.3.1             Product launches & approvals            273

11.1.11.3.2             Deals      273

11.1.12   OLYMPUS CORPORATION           274

11.1.12.1                 Business overview 274

11.1.12.2                 Products offered   275

11.1.12.3                 Recent developments           275

11.1.12.3.1             PRODUCT LAUNCHES AND APPROVALS                 276

11.1.12.3.2             Deals      276

11.1.12.3.3             Expansions             276

11.1.13   NOVANTA INC. 277

11.1.13.1                 Business overview 277

11.1.13.2                 Products offered   279

11.1.13.3                 Recent developments           279

11.1.13.3.1             Deals      279

11.1.14   GLOBUS MEDICAL          280

11.1.14.1                 Business overview 280

11.1.14.2                 Products offered   281

11.1.14.3                 Recent developments           282

11.1.14.3.1             Product launches & approvals            282

11.1.14.3.2             Deals      282

11.1.15   SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.      283

11.1.15.1                 Business overview 283

11.1.15.2                 Products offered   285

11.1.15.3                 Recent developments           286

11.1.15.3.1             Product launches & approvals            286

11.1.16   SONY ELECTRONICS INC.             287

11.1.16.1                 Business overview 287

11.1.16.2                 Products offered   287

11.1.16.3                 Recent developments           288

11.1.16.3.1             Product launches & approvals            288

11.1.16.3.2             Deals      288

11.1.17   UNITED IMAGING HEALTHCARE CO., LTD.         289

11.1.17.1                 Business overview 289

11.1.17.2                 Products offered   290

11.1.17.3                 Recent developments           290

11.1.17.3.1             Product launches & approvals            290

11.1.18   BARCO 291

11.1.18.1                 Business overview 291

11.1.18.2                 Products offered   292

11.1.18.3                 Recent developments           293

11.1.18.3.1             Product launches & approvals            293

11.1.18.3.2             Deals      293

11.1.19   AUXEIN 294

11.1.19.1                 Business overview 294

11.1.19.2                 Products offered   295

11.1.19.3                 Recent developments           295

11.1.19.3.1             Product launches & approvals            295

11.1.20   BRAINLAB SE     296

11.1.20.1                 Business overview 296

11.1.20.2                 Products offered   296

11.1.20.3                 Recent developments           297

11.1.20.3.1             Deals      297

11.2         OTHER PLAYERS              298

11.2.1      TRIVITRON HEALTHCARE           298

11.2.2      RGS HEALTHCARE           299

11.2.3      GEMSS HEALTHCARE CO., LTD.                 300

11.2.4      SKANRAY TECHNOLOGIES LIMITED       301

11.2.5      NANJING PERLOVE MEDICAL EQUIPMENT CO., LTD.                 302

11.2.6      ARTHREX, INC. 303

12            APPENDIX           304

12.1         DISCUSSION GUIDE        304

12.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                308

12.3         CUSTOMIZATION OPTIONS        310

12.4         RELATED REPORTS         310

12.5         AUTHOR DETAILS           311

LIST OF TABLES

TABLE 1                SURGICAL IMAGING MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS           55

TABLE 2                AVERAGE SELLING PRICE OF TOP PRODUCTS, BY KEY PLAYER, 2024      64

TABLE 3                AVERAGE SELLING PRICE TREND OF SURGICAL IMAGING PRODUCTS,

BY REGION, 2022–2024    65

TABLE 4                SURGICAL IMAGING MARKET: ROLE OF COMPANIES IN ECOSYSTEM       71

TABLE 5                JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR SURGICAL IMAGING MARKET (2025)    75

TABLE 6                IMPORT DATA FOR SURGICAL IMAGING PRODUCTS (HS CODE 9022),

BY COUNTRY, 2020–2024 (USD THOUSAND)         78

TABLE 7                EXPORT DATA FOR SURGICAL IMAGING PRODUCTS (HS CODE 9022),

BY COUNTRY, 2020–2024 (USD THOUSAND)         79

TABLE 8                SURGICAL IMAGING MARKET: DETAILED LIST OF MAJOR CONFERENCES AND EVENTS, 2025–2026           79

TABLE 9                TARIFF DATA FOR HS CODE 9022              82

TABLE 10              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 83

TABLE 11              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  83

TABLE 12              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  84

TABLE 13              LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  85

TABLE 14              MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 85

TABLE 15              US FDA: MEDICAL DEVICE CLASSIFICATION                 86

TABLE 16              US: APPROVED IMAGING DEVICES BY FDA                 86

TABLE 17              US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS              87

TABLE 18              CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS      87

TABLE 19              JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA   89

TABLE 20              CHINA: CLASSIFICATION OF MEDICAL DEVICES                 89

TABLE 21              MEDICAL REIMBURSEMENT CPT CODES FOR SURGICAL PROCEDURES IN US, 2025       92

TABLE 22              SURGICAL IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS           93

TABLE 23              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%)        96

TABLE 24              KEY BUYING CRITERIA FOR END USERS                 97

TABLE 25              UNMET NEEDS IN SURGICAL IMAGING MARKET                 98

TABLE 26              END-USER EXPECTATIONS IN SURGICAL IMAGING MARKET           99

TABLE 27              US ADJUSTED RECIPROCAL TARIFF RATES (AS OF AUGUST 2025)             107

TABLE 28              SURGICAL IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            112

TABLE 29              C-ARMS SURGICAL IMAGING MARKET, BY OFFERINGS OF MAJOR PLAYERS                113

TABLE 30              C-ARMS: SURGICAL IMAGING MARKET, BY REGION, 2023–2030 (USD MILLION)          113

TABLE 31              C-ARMS: SURGICAL IMAGING MARKET, BY APPLICATION (PROCEDURE TYPE), 2023–2030 (USD MILLION)                 114

TABLE 32              C-ARMS: SURGICAL IMAGING MARKET, BY APPLICATION (SURGERY TYPE),

2023–2030 (USD MILLION)            114

TABLE 33              C-ARMS: SURGICAL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)                115

TABLE 34              CT SCANNERS: SURGICAL IMAGING MARKET, BY REGION,

2023–2030 (USD MILLION)            116

TABLE 35              CT SCANNERS: SURGICAL IMAGING MARKET, BY APPLICATION (PROCEDURE TYPE), 2023–2030 (USD MILLION)            116

TABLE 36              CT SCANNERS: SURGICAL IMAGING MARKET, BY APPLICATION (SURGERY TYPE), 2023–2030 (USD MILLION)                 117

TABLE 37              CT SCANNERS: SURGICAL IMAGING MARKET, BY END USER,

2023–2030 (USD MILLION)            117

TABLE 38              ULTRASOUND SYSTEMS: SURGICAL IMAGING MARKET, BY REGION,

2023–2030 (USD MILLION)            118

TABLE 39              ULTRASOUND SYSTEMS: SURGICAL IMAGING MARKET, BY APPLICATION (PROCEDURE TYPE), 2023–2030 (USD MILLION)            119

TABLE 40              ULTRASOUND SYSTEMS: SURGICAL IMAGING MARKET, BY APPLICATION (SURGERY TYPE), 2023–2030 (USD MILLION)            119

TABLE 41              ULTRASOUND SYSTEMS: SURGICAL IMAGING MARKET, BY END USER,

2023–2030 (USD MILLION)            120

TABLE 42              INTEGRATED MR-OR SYSTEMS: SURGICAL IMAGING MARKET, BY REGION,

2023–2030 (USD MILLION)            121

TABLE 43              INTEGRATED MR-OR SYSTEMS: SURGICAL IMAGING MARKET, BY APPLICATION (PROCEDURE TYPE), 2023–2030 (USD MILLION)       121

TABLE 44              INTEGRATED MR-OR SYSTEMS: SURGICAL IMAGING MARKET, BY APPLICATION (SURGERY TYPE, 2023–2030 (USD MILLION)       122

TABLE 45              INTEGRATED MR-OR SYSTEMS: SURGICAL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)                 122

TABLE 46              SURGICAL NAVIGATION SOFTWARE: SURGICAL IMAGING MARKET, BY REGION, 2023–2030 (USD MILLION)                 123

TABLE 47              SURGICAL NAVIGATION SOFTWARE: SURGICAL IMAGING MARKET, BY APPLICATION (PROCEDURE TYPE), 2023–2030 (USD MILLION)       124

TABLE 48              SURGICAL NAVIGATION SOFTWARE: SURGICAL IMAGING MARKET, BY APPLICATION (SURGERY TYPE), 2023–2030 (USD MILLION)       124

TABLE 49              SURGICAL NAVIGATION SOFTWARE: SURGICAL IMAGING MARKET,

BY END USER, 2023–2030 (USD MILLION)               125

TABLE 50              ACCESSORIES: SURGICAL IMAGING MARKET, BY REGION,

2023–2030 (USD MILLION)            126

TABLE 51              ACCESSORIES: SURGICAL IMAGING MARKET, BY APPLICATION (PROCEDURE TYPE), 2023–2030 (USD MILLION)                 126

TABLE 52              ACCESSORIES: SURGICAL IMAGING MARKET, BY APPLICATION

(SURGERY TYPE), 2023–2030 (USD MILLION)       127

TABLE 53              ACCESSORIES: SURGICAL IMAGING MARKET, BY END USER,

2023–2030 (USD MILLION)            127

TABLE 54              SURGICAL IMAGING MARKET, BY PROCEDURE TYPE, 2023–2030 (USD MILLION)                129

TABLE 55              PROCEDURE TYPE: SURGICAL IMAGING MARKET, BY REGION,

2023–2030 (USD MILLION)            130

TABLE 56              MINIMALLY INVASIVE SURGERY: SURGICAL IMAGING MARKET, BY REGION,

2023–2030 (USD MILLION)            131

TABLE 57              LAPAROSCOPY: SURGICAL IMAGING MARKET, BY REGION,

2023–2030 (USD MILLION)            132

TABLE 58              ENDOSCOPY: SURGICAL IMAGING MARKET, BY REGION,

2023–2030 (USD MILLION)            133

TABLE 59              OTHER PROCEDURES: SURGICAL IMAGING MARKET, BY REGION,

2023–2030 (USD MILLION)            134

TABLE 60              SURGICAL IMAGING MARKET, BY SURGERY TYPE, 2023–2030 (USD MILLION)                135

TABLE 61              SURGERY TYPE: SURGICAL IMAGING MARKET, BY REGION,

2023–2030 (USD MILLION)            135

TABLE 62              GENERAL SURGERY: SURGICAL IMAGING MARKET, BY REGION,

2023–2030 (USD MILLION)            136

TABLE 63              CARDIOVASCULAR SURGERY: SURGICAL IMAGING MARKET, BY REGION,

2023–2030 (USD MILLION)            137

TABLE 64              OB/GYN SURGERY: SURGICAL IMAGING MARKET, BY REGION,

2023–2030 (USD MILLION)            138

TABLE 65              ORTHOPEDIC & MUSCULOSKELETAL SURGERY: SURGICAL IMAGING MARKET,

BY REGION, 2023–2030 (USD MILLION)   139

TABLE 66             NEUROSURGERY: SURGICAL IMAGING MARKET, BY REGION,

2023–2030 (USD MILLION)            140

TABLE 67              UROLOGY SURGERY: SURGICAL IMAGING MARKET, BY REGION,

2023–2030 (USD MILLION)            141

TABLE 68              OTHER SURGERIES: SURGICAL IMAGING MARKET, BY REGION,

2023–2030 (USD MILLION)            142

TABLE 69              SURGICAL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)            144

TABLE 70              SURGICAL IMAGING MARKET FOR HOSPITALS & SURGICAL CENTERS,

BY REGION, 2023–2030 (USD MILLION)   145

TABLE 71              SURGICAL IMAGING MARKET FOR SPECIALTY CLINICS, BY REGION,

2023–2030 (USD MILLION)            146

TABLE 72              SURGICAL IMAGING MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2023–2030 (USD MILLION)            147

TABLE 73              SURGICAL IMAGING MARKET FOR OTHER END USERS, BY REGION,

2023–2030 (USD MILLION)            148

TABLE 74              SURGICAL IMAGING MARKET, BY REGION, 2023–2030 (USD MILLION)       150

TABLE 75              NORTH AMERICA: MACROECONOMIC OUTLOOK           152

TABLE 76             NORTH AMERICA: SURGICAL IMAGING MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            153

TABLE 77             NORTH AMERICA: SURGICAL IMAGING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            153

TABLE 78             NORTH AMERICA: SURGICAL IMAGING MARKET, BY APPLICATION (PROCEDURE TYPE), 2023–2030 (USD MILLION)            154

TABLE 79             NORTH AMERICA: SURGICAL IMAGING MARKET, BY APPLICATION (SURGERY TYPE), 2023–2030 (USD MILLION)                 154

TABLE 80             NORTH AMERICA: SURGICAL IMAGING MARKET, BY END USER,

2023–2030 (USD MILLION)            155

TABLE 81             US: SURGICAL IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            156

TABLE 82              CANADA: SURGICAL IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     157

TABLE 83              EUROPE: MACROECONOMIC OUTLOOK                 158

TABLE 84              EUROPE: SURGICAL IMAGING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     159

TABLE 85              EUROPE: SURGICAL IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     159

TABLE 86              EUROPE: SURGICAL IMAGING MARKET, BY APPLICATION (PROCEDURE TYPE), 2023–2030 (USD MILLION)                 160

TABLE 87              EUROPE: SURGICAL IMAGING MARKET, BY APPLICATION (SURGERY TYPE),

2023–2030 (USD MILLION)            160

TABLE 88              EUROPE: SURGICAL IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)                161

TABLE 89              GERMANY: SURGICAL IMAGING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            162

TABLE 90             UK: SURGICAL IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            163

TABLE 91              FRANCE: SURGICAL IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     164

TABLE 92              ITALY: SURGICAL IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     165

TABLE 93              SPAIN: SURGICAL IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     166

TABLE 94             REST OF EUROPE: SURGICAL IMAGING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            167

TABLE 95              ASIA PACIFIC: MACROECONOMIC OUTLOOK                 168

TABLE 96              ASIA PACIFIC: SURGICAL IMAGING MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            170

TABLE 97              ASIA PACIFIC: SURGICAL IMAGING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            170

TABLE 98              ASIA PACIFIC: SURGICAL IMAGING MARKET, BY APPLICATION (PROCEDURE TYPE), 2023–2030 (USD MILLION)                 171

TABLE 99              ASIA PACIFIC: SURGICAL IMAGING MARKET, BY APPLICATION (SURGERY TYPE), 2023–2030 (USD MILLION)                 171

TABLE 100            ASIA PACIFIC: SURGICAL IMAGING MARKET, BY END USER,

2023–2030 (USD MILLION)            172

TABLE 101            JAPAN: SURGICAL IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     173

TABLE 102            CHINA: SURGICAL IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     174

TABLE 103            INDIA: SURGICAL IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     175

TABLE 104            SOUTH KOREA: SURGICAL IMAGING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            176

TABLE 105            AUSTRALIA: SURGICAL IMAGING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            177

TABLE 106            REST OF ASIA PACIFIC: SURGICAL IMAGING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            178

TABLE 107            LATIN AMERICA: MACROECONOMIC OUTLOOK                 179

TABLE 108            LATIN AMERICA: SURGICAL IMAGING MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            179

TABLE 109            LATIN AMERICA: SURGICAL IMAGING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            180

TABLE 110            LATIN AMERICA: SURGICAL IMAGING MARKET, BY APPLICATION (PROCEDURE TYPE), 2023–2030 (USD MILLION)            180

TABLE 111            LATIN AMERICA: SURGICAL IMAGING MARKET, BY APPLICATION (SURGERY TYPE), 2023–2030 (USD MILLION)                 181

TABLE 112            LATIN AMERICA: SURGICAL IMAGING MARKET, BY END USER,

2023–2030 (USD MILLION)            181

TABLE 113            BRAZIL: SURGICAL IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     182

TABLE 114            MEXICO: SURGICAL IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     183

TABLE 115            REST OF LATIN AMERICA: SURGICAL IMAGING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            184

TABLE 116            MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK           186

TABLE 117            MIDDLE EAST & AFRICA: SURGICAL IMAGING MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            186

TABLE 118            MIDDLE EAST & AFRICA: SURGICAL IMAGING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            187

TABLE 119            MIDDLE EAST & AFRICA: SURGICAL IMAGING MARKET, BY APPLICATION (PROCEDURE TYPE), 2023–2030 (USD MILLION)            187

TABLE 120            MIDDLE EAST & AFRICA: SURGICAL IMAGING MARKET, BY APPLICATION (SURGERY TYPE), 2023–2030 (USD MILLION)            188

TABLE 121            MIDDLE EAST & AFRICA: SURGICAL IMAGING MARKET, BY END USER,

2023–2030 (USD MILLION)            188

TABLE 122          GCC COUNTRIES: SURGICAL IMAGING MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            189

TABLE 123            REST OF MIDDLE EAST & AFRICA: SURGICAL IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)                 190

TABLE 124            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SURGICAL IMAGING MARKET, JANUARY 2022–AUGUST 2025     192

TABLE 125            SURGICAL IMAGING MARKET: DEGREE OF COMPETITION 195

TABLE 126            SURGICAL IMAGING MARKET: REGION FOOTPRINT       200

TABLE 127            SURGICAL IMAGING MARKET: PRODUCT FOOTPRINT       201

TABLE 128            SURGICAL IMAGING MARKET: APPLICATION (PROCEDURE TYPE) FOOTPRINT             202

TABLE 129            SURGICAL IMAGING MARKET: APPLICATION (SURGERY TYPE) FOOTPRINT   203

TABLE 130            SURGICAL IMAGING MARKET: END-USER FOOTPRINT       204

TABLE 131            SURGICAL IMAGING MARKET: DETAILED LIST OF KEY STARTUPS/SMES              207

TABLE 132            SURGICAL IMAGING MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS                 208

TABLE 133            SURGICAL IMAGING MARKET: PRODUCT LAUNCHES,

JANUARY 2022–AUGUST 2025       211

TABLE 134            SURGICAL IMAGING MARKET: DEALS, JANUARY 2022–AUGUST 2025           212

TABLE 135            SURGICAL IMAGING MARKET: EXPANSIONS, JANUARY 2022–AUGUST 2025       213

TABLE 136            GE HEALTHCARE: COMPANY OVERVIEW                 214

TABLE 137            GE HEALTHCARE: PRODUCTS OFFERED                 216

TABLE 138            GE HEALTHCARE: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2022–AUGUST 2025       217

TABLE 139            GE HEALTHCARE: DEALS, JANUARY 2022–AUGUST 2025     219

TABLE 140            GE HEALTHCARE: EXPANSIONS, JANUARY 2022–AUGUST 2025     223

TABLE 141            SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW          225

TABLE 142            SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED             227

TABLE 143            SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–AUGUST 2025                 229

TABLE 144            SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2022–AUGUST 2025           231

TABLE 145            SIEMENS HEALTHINEERS AG: OTHER DEVELOPMENTS,

JANUARY 2022–AUGUST 2025     232

TABLE 146            SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2022–AUGUST 2025       232

TABLE 147            KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW          234

TABLE 148            KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED             236

TABLE 149            KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2022–AUGUST 2025       237

TABLE 150            KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2022–AUGUST 2025           239

TABLE 151            SHIMADZU CORPORATION: COMPANY OVERVIEW          241

TABLE 152            SHIMADZU CORPORATION: PRODUCTS OFFERED             243

TABLE 153            SHIMADZU CORPORATION: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2022–AUGUST 2025       244

TABLE 154            SHIMADZU CORPORATION: DEALS, JANUARY 2022–AUGUST 2025           245

TABLE 155            FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW   247

TABLE 156            FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED    249

TABLE 157            FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2022–AUGUST 2025       250

TABLE 158            FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2022–AUGUST 2025       250

TABLE 159            ZIEHM IMAGING GMBH: COMPANY OVERVIEW                 253

TABLE 160            ZIEHM IMAGING GMBH: PRODUCTS OFFERED                 253

TABLE 161            ZIEHM IMAGING GMBH: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2022–AUGUST 2025       255

TABLE 162            ZIEHM IMAGING GMBH: DEALS, JANUARY 2022–AUGUST 2025     255

TABLE 163            HOLOGIC, INC.: COMPANY OVERVIEW  256

TABLE 164            HOLOGIC, INC.: PRODUCTS OFFERED   258

TABLE 165            HOLOGIC, INC.: DEALS, JANUARY 2022–AUGUST 2025        259

TABLE 166            SMITH+NEPHEW: COMPANY OVERVIEW                 260

TABLE 167            SMITH+NEPHEW: PRODUCTS OFFERED                 261

TABLE 168            SMITH+NEPHEW: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2022–AUGUST 2025       262

TABLE 169            SMITH+NEPHEW: DEALS, JANUARY 2022–AUGUST 2025     262

TABLE 170            MEDTRONIC: COMPANY OVERVIEW       263

TABLE 171            MEDTRONIC: PRODUCTS OFFERED        264

TABLE 172            MEDTRONIC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–AUGUST 2025            266

TABLE 173            MEDTRONIC: DEALS, JANUARY 2022–AUGUST 2025        266

TABLE 174            STRYKER: COMPANY OVERVIEW               267

TABLE 175            STRYKER: PRODUCTS OFFERED                268

TABLE 176            STRYKER: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–AUGUST 2025       269

TABLE 177            STRYKER: DEALS, JANUARY 2022–AUGUST 2025                 269

TABLE 178            CANON INC.: COMPANY OVERVIEW        270

TABLE 179            CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS OFFERED    272

TABLE 180            CANON MEDICAL SYSTEMS CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–AUGUST 2025        273

TABLE 181            CANON MEDICAL SYSTEMS CORPORATION: DEALS, JANUARY 2022–AUGUST 2025       273

TABLE 182            OLYMPUS CORPORATION: COMPANY OVERVIEW          274

TABLE 183            OLYMPUS CORPORATION: PRODUCTS OFFERED             275

TABLE 184            OLYMPUS CORPORATION: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2022–AUGUST 2025       276

TABLE 185            OLYMPUS CORPORATION: DEALS, JANUARY 2022–AUGUST 2025           276

TABLE 186            OLYMPUS CORPORATION: EXPANSIONS, JANUARY 2022–AUGUST 2025       276

TABLE 187            NOVANTA INC.: COMPANY OVERVIEW  277

TABLE 188            NOVANTA INC.: PRODUCTS OFFERED   279

TABLE 189            NOVANTA INC.: DEALS, JANUARY 2022–AUGUST 2025        279

TABLE 190            GLOBUS MEDICAL: COMPANY OVERVIEW                 280

TABLE 191            GLOBUS MEDICAL: PRODUCTS OFFERED                 281

TABLE 192            GLOBUS MEDICAL: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2022–AUGUST 2025       282

TABLE 193            GLOBUS MEDICAL: DEALS, JANUARY 2022–AUGUST 2025     282

TABLE 194            SHENZHEN MINDRAY: COMPANY OVERVIEW                 283

TABLE 195            SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED 285

TABLE 196            SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–AUGUST 2025       286

TABLE 197            SONY ELECTRONICS INC.: COMPANY OVERVIEW          287

TABLE 198            SONY ELECTRONICS INC.: PRODUCTS OFFERED                 287

TABLE 199            SONY ELECTRONICS INC.: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2022–MAY 2025               288

TABLE 200            SONY ELECTRONICS INC: DEALS, JANUARY 2022–AUGUST 2025           288

TABLE 201            UNITED IMAGING HEALTHCARE CO., LTD.: COMPANY OVERVIEW   289

TABLE 202            UNITED IMAGING HEALTHCARE CO., LTD.: PRODUCTS OFFERED    290

TABLE 203            UNITED IMAGING HEALTHCARE CO., LTD.: PRODUCT LAUNCHES &

APPROVALS, JANUARY 2022–AUGUST 2025            290

TABLE 204            BARCO: COMPANY OVERVIEW  291

TABLE 205            BARCO: PRODUCTS OFFERED   292

TABLE 206            BARCO: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–AUGUST 2025       293

TABLE 207            BARCO: DEALS, JANUARY 2022–AUGUST 2025                 293

TABLE 208            AUXEIN: COMPANY OVERVIEW 294

TABLE 209            AUXEIN: PRODUCTS OFFERED  295

TABLE 210            AUXEIN: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–AUGUST 2025       295

TABLE 211            BRAINLAB SE: COMPANY OVERVIEW      296

TABLE 212            BRAINLAB SE: PRODUCTS OFFERED       296

TABLE 213            BRAINLAB SE: DEALS, JANUARY 2022–AUGUST 2025        297

TABLE 214            TRIVITRON HEALTHCARE: COMPANY OVERVIEW          298

TABLE 215            RGS HEALTHCARE: COMPANY OVERVIEW                 299

TABLE 216            GEMSS HEALTHCARE CO., LTD.: COMPANY OVERVIEW          300

TABLE 217            SKANRAY TECHNOLOGIES LIMITED: COMPANY OVERVIEW          301

TABLE 218            NANJING PERLOVE MEDICAL EQUIPMENT CO., LTD.: COMPANY OVERVIEW       302

TABLE 219            ARTHREX, INC.: COMPANY OVERVIEW  303

LIST OF FIGURES

FIGURE 1              MARKET AND REGIONAL SEGMENTATION                 27

FIGURE 2              SURGICAL IMAGING MARKET: RESEARCH DESIGN                31

FIGURE 3              BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,

DESIGNATION, AND REGION     35

FIGURE 4              RESEARCH METHODOLOGY: HYPOTHESIS BUILDING           36

FIGURE 5              MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS            37

FIGURE 6              SURGICAL IMAGING MARKET: BOTTOM-UP APPROACH         38

FIGURE 7              CAGR PROJECTIONS      39

FIGURE 8              DATA TRIANGULATION METHODOLOGY                 40

FIGURE 9              SURGICAL IMAGING MARKET, BY PRODUCT, 2025 VS. 2030       43

FIGURE 10            SURGICAL IMAGING MARKET, BY APPLICATION (PROCEDURE TYPE),

2025 VS. 2030       44

FIGURE 11            SURGICAL IMAGING MARKET, BY APPLICATION (SURGERY TYPE), 2025 VS. 2030  45

FIGURE 12            SURGICAL IMAGING MARKET, BY END USER, 2025 VS. 2030       46

FIGURE 13            SURGICAL IMAGING MARKET: REGIONAL SNAPSHOT          47

FIGURE 14            GROWING DEMAND FOR MINIMALLY INVASIVE SURGERIES AND ADVANCEMENTS IN INTRAOPERATIVE IMAGING TO DRIVE MARKET     49

FIGURE 15            C-ARMS SEGMENT AND JAPAN TO COMMAND LARGEST SHARES OF ASIA PACIFIC MARKET IN 2024        50

FIGURE 16            MARKET IN CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD          51

FIGURE 17            ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD       52

FIGURE 18            EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD    53

FIGURE 19            SURGICAL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES         54

FIGURE 20            REVENUE SHIFT AND NEW REVENUE POCKETS IN SURGICAL IMAGING MARKET               61

FIGURE 21            AVERAGE SELLING PRICE TREND OF SURGICAL IMAGING PRODUCTS,

BY TYPE, 2024     63

FIGURE 22            AVERAGE SELLING PRICE TREND OF SURGICAL IMAGING PRODUCTS,

BY KEY PLAYER, 2024      64

FIGURE 23            AVERAGE SELLING PRICE TREND OF SURGICAL IMAGING PRODUCTS,

BY REGION, 2024               65

FIGURE 24            SURGICAL IMAGING MARKET: VALUE CHAIN ANALYSIS            68

FIGURE 25            SURGICAL IMAGING MARKET: SUPPLY CHAIN ANALYSIS            69

FIGURE 26            SURGICAL IMAGING MARKET: ECOSYSTEM ANALYSIS            70

FIGURE 27            INVESTMENT AND FUNDING SCENARIO                 72

FIGURE 28            JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR SURGICAL IMAGING MARKET (2025)    75

FIGURE 29            SURGICAL IMAGING MARKET: TOP PATENT OWNERS/PATENTING TRENDS,

2015–2025              77

FIGURE 30            SURGICAL IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS           94

FIGURE 31            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER                96

FIGURE 32            KEY BUYING CRITERIA FOR END USERS                 97

FIGURE 33            MARKET POTENTIAL OF AI/GEN AI ON SURGICAL IMAGING ACROSS INDUSTRIES           102

FIGURE 34            IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS   104

FIGURE 35            NORTH AMERICA: SURGICAL IMAGING MARKET SNAPSHOT, 2024               152

FIGURE 36            ASIA PACIFIC: SURGICAL IMAGING MARKET SNAPSHOT, 2024               169

FIGURE 37            REVENUE ANALYSIS OF KEY PLAYERS IN SURGICAL IMAGING MARKET,

2020–2024              194

FIGURE 38            MARKET SHARE ANALYSIS OF KEY PLAYERS IN SURGICAL IMAGING MARKET, 2024          195

FIGURE 39            SURGICAL IMAGING MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2024       198

FIGURE 40            SURGICAL IMAGING MARKET: COMPANY FOOTPRINT       199

FIGURE 41            SURGICAL IMAGING MARKET: COMPANY EVALUATION MATRIX

(STARTUPS/SMES), 2024                206

FIGURE 42            EV/EBITDA OF KEY VENDORS   208

FIGURE 43            YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK

BETA OF KEY VENDORS                209

FIGURE 44            SURGICAL IMAGING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS     210

FIGURE 45            GE HEALTHCARE: COMPANY SNAPSHOT (2024)                 215

FIGURE 46            SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2024)             226

FIGURE 47            KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024)             235

FIGURE 48            SHIMADZU CORPORATION: COMPANY SNAPSHOT (2024)             242

FIGURE 49            FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2024)      248

FIGURE 50            HOLOGIC, INC.: COMPANY SNAPSHOT (2024)                 257

FIGURE 51            SMITH+NEPHEW: COMPANY SNAPSHOT (2024)                 261

FIGURE 52            MEDTRONIC: COMPANY SNAPSHOT (2024)                 264

FIGURE 53            STRYKER: COMPANY SNAPSHOT (2024) 268

FIGURE 54            CANON INC.: COMPANY SNAPSHOT (2024)                 271

FIGURE 55            OLYMPUS CORPORATION: COMPANY SNAPSHOT (2024)             275

FIGURE 56            NOVANTA INC.: COMPANY SNAPSHOT (2024)                 278

FIGURE 57            GLOBUS MEDICAL: COMPANY SNAPSHOT (2024)    281

FIGURE 58            SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.:

COMPANY SNAPSHOT (2024)      284

FIGURE 59            UNITED IMAGING HEALTHCARE CO., LTD.: COMPANY SNAPSHOT (2024)      289

FIGURE 60            BARCO: COMPANY SNAPSHOT (2024)     292

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 精密林業市場規模、シェア、動向、2030年までの世界予測 2025-11-05
• フィールドサービス管理市場規模、シェア、動向、2030年までの世界予測 2025-11-05
• 採血装置市場規模、シェア、動向、2030年までの世界予測 2025-11-04
• 車載半導体市場規模、シェア、動向、2030年までの世界予測 2025-11-04
• データセンターUPS市場規模、シェア、動向、2030年までの世界予測 2025-10-31

MarketsandMarkets  出版レポート一覧